<DOC>
	<DOCNO>NCT00697021</DOCNO>
	<brief_summary>TEG establish technique ass quality clot formation ' use mainly surgery obstetrics determine possible bleeding diathesis . Recently become used cardiology , valuable tool ass response antiplatelet therapy association outcome . However , data use TEG STEMI patient undergo PCI . Our study design ass TEG platelet 's response clopidogrel treatment acute STEMI patient undergo primary PCI correlation response long term outcome , ability dose adjustment accord specific measurement TEG order prevent future MACE .</brief_summary>
	<brief_title>Thromboelastography As An Assessment Tool Possible Clopidogrel Aspirin Resistance</brief_title>
	<detailed_description>TEG system may provide capability need deliver personalized therapy , first , identify patient risk ischemic event base hemostatic influence , particularly platelet aggregation platelet reactivity . Secondly , treat patient exhibit high platelet reactivity -- indication reach therapeutic level -- appropriate drug dos expect improve outcome . In study would increase clopidogrel maintenance dosing ( 150 mg ) aspirin maintenance dose 200mg attempt low platelet reactivity 50th % ile , expect also reduce ischemic risk follow period .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Patients 18 year age Patients admit acute STEMI first Coronary event Duration symptoms less 12 hour PCI elect treatment acute STEMI Informed consent sign Thrombolytic therapy PCI perform diagnostic angiography ( conservative treatment , CABG ) DES use PPCI Staged PCI procedures Previous clopidogrel treatment time reason Previous myocardial infarction Known bleed diathesis kind Significant renal insufficiency ( GFR &lt; 40 ml/min ) LFT disturbance ( Transaminase elevation x3 ULN ) Significant anemia ( Hb &lt; 10 ) need blood transfusion Significant Thrombocytopenia ( PLT Count &lt; 150000 ) Known Clopidogrel allergy Known Active peptic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Thromboelastography</keyword>
	<keyword>Aspirin</keyword>
	<keyword>Clopidogrel</keyword>
	<keyword>Plavix</keyword>
	<keyword>Resistance</keyword>
	<keyword>Platelet</keyword>
	<keyword>Coronary Stenting</keyword>
	<keyword>Bare Metal Stent</keyword>
	<keyword>Dual antiplatelet therapy</keyword>
	<keyword>Overreactivity</keyword>
	<keyword>Primary Coronary Intervention</keyword>
</DOC>